Adagio Medical Holdings (ADGM) Cash from Operations (2023 - 2026)

Adagio Medical Holdings has disclosed Cash from Operations across 4 years of filings, most recently posting -$5.3 million for Q2 2026.

• In Q2 2026, Cash from Operations fell 12.48% year-over-year to -$5.3 million; the TTM figure through Jun 2026 stood at -$18.2 million (up 27.3% YoY), while the FY2025 annual figure was -$19.0 million, down 41.17% from the prior year.
• Cash from Operations came in at -$5.3 million for Q2 2026 at Adagio Medical Holdings, down from -$4.1 million in the prior quarter.
• In the past five years, Cash from Operations ranged from a high of -$4.1 million in Q4 2025 to a low of -$7.2 million in Q1 2025.
• Average Cash from Operations over 4 years is -$5.7 million, with a median of -$5.8 million recorded in 2024.
• The largest YoY upside for Cash from Operations was 42.78% in 2026 against a maximum downside of 12.48% in 2026.
• Over 4 years, Cash from Operations stood at -$7.1 million in 2023, then advanced by 9.86% to -$6.4 million in 2024, then surged by 35.72% to -$4.1 million in 2025, then fell by 28.2% to -$5.3 million in 2026.
• Per Business Quant data, the three most recent Cash from Operations figures were -$5.3 million in Q2 2026, -$4.1 million in Q1 2026, and -$4.1 million in Q4 2025.